BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

Advanced Search

31 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Chemical update on the potential for serotonin 5-HTEBI
Jagiellonian University
Abolishing Dopamine DEBI
University of Regensburg
Discovery and characterization of benzyloxy piperidine based dopamine 4 receptor antagonists.EBI
University of Nebraska Medical Center
Discovery of Highly Potent Serotonin 5-HTEBI
Northwestern University
BOPPY-based novel fluorescent dopamine DEBI
Heinrich Heine University D£Sseldorf
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification.EBI
Zhejiang University
Design and synthesis of new potent 5-HTEBI
Cracow University of Technology
2-(Fluoromethoxy)-4'-(EBI
Universidad Complutense De Madrid
Distal kinetic deuterium isotope effect: Phenyl ring deuteration attenuates N-demethylation of Lu AF35700.EBI
H. Lundbeck
Discovery of potent dual ligands for dopamine D4 and ?1 receptors.EBI
Bioprojet-Biotech
Structure-Activity Relationship and Neuroprotective Activity of 1,5-Dihydro-2EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Highly Potent and Selective Dopamine DEBI
Universit£
Structure-Activity Studies of 1EBI
National Institute of Diabetes and Digestive and Kidney Diseases
Novel Dual-Target ?-Opioid Receptor and Dopamine DEBI
National Institute On Drug Abuse-Intramural Research Program
Bridged Piperidine Analogues of a High Affinity Naphthalene-Based P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Selective AEBI
National Institute of Diabetes and Digestive and Kidney Diseases
Adenosine AEBI
Heinrich Heine University Duesseldorf
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HTEBI
Jagiellonian University Medical College
2-Phenylcyclopropylmethylamine Derivatives as Dopamine DEBI
Shanghaitech University
Structure Activity Relationships for a Series of Eticlopride-Based Dopamine DEBI
National Institute On Drug Abuse - Intramural Research Program
Design, synthesis and preliminary bioactivity evaluation of bitopic benzopyranomorpholine analogues as selective dopamine D3 receptor ligands as anti-drug addiction therapeutic agents.EBI
Southeast University
New tetrahydroisoquinoline-based DEBI
City University of New York
Radioligand and computational insight in structure - Activity relationship of saccharin derivatives being ipsapirone and revospirone analogues.EBI
Cracow University of Technology
Discovery of a new class of multi-target heterocycle piperidine derivatives as potential antipsychotics with pro-cognitive effect.EBI
Huazhong University of Science and Technology
Structure activity relationship of 3-nitro-2-(trifluoromethyl)-2H-chromene derivatives as P2YEBI
National Institute of Diabetes and Digestive and Kidney Diseases
New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.EBI
Florida A&M University
Pharmacological characterization of a new series of carbamoylguanidines reveals potent agonism at the HEBI
University of Regensburg